Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

novartis_outside_1

Novartis to invest $100m in new malaria treatments

April 17, 2018 Manufacturing and Production, Research and Development Novartis, WHO, malaria, pharma

Novartis has revealed it is to invest $100 million into the research and development of new treatments for malaria over …
News
merckwindow_web

Keytruda success continues, beating Opdivo in lung cancer survival

April 17, 2018 Manufacturing and Production, Research and Development Cancer, MSD, NSCLC, keytruda, lung cancer, pharma

Not content with revealing two strong waves of data on its flagship immunotherapy Keytruda (pembrolizumab) over the past weeks, MSD …
News
pharmacy-3087596_960_720

Care packaging: Inside the Falsified Medicines Directive

April 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, packaging, pharma, pharmaceutical

When it comes to the pharmaceutical supply chain, patient safety has and will always be a primary concern for all …
Feature
novartis_outside_1

Novartis’ Entresto helps preserve kidney function in chronic heart failure patients

April 16, 2018 Research and Development, Sales and Marketing Entresto, Novartis, heart failure, pharma

Novartis has lifted the curtain on new data from a Phase 3 trial investigating the efficacy of Entresto (sacubitril/valsartan) in …
News

J&J’s ketamine nasal spray for depression continues to impress

April 16, 2018 Research and Development, Sales and Marketing Johnson & Johnson, Ketamine, biotech, drugs, pharma, pharmaceutical

New treatments for depression are few and far between; pharmaceutical companies have shied away from trying to develop new therapeutics …
News
merckentranceweb

Keytruda continues success with new Phase 3 data in adjuvant melanoma

April 16, 2018 Research and Development, Sales and Marketing Cancer, MSD, keytruda, melanoma, pharma, skinc cancer

MSD has revealed new efficacy data for Keytruda (permbrolizumab) as an adjuvant therapy in the treatment of resected, high-risk stage …
News

Visit Us! DIA’s Refreshed Homepage Design

April 13, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

We’re excited to share with you our recently redesigned homepage, at the same site address: DIAglobal.org. The main objectives of …
News
Press release

PrimeVigilance celebrates its 10th anniversary

April 13, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing primevigilance

PrimeVigilance will be exhibiting and celebrating its 10th anniversary at #DIAEurope2018, raffling 10 bottles of champagne away! Stop by their …
News
Press release
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

April 13, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Cancer, Humira, Mylan, Novartis, Shire, Takeda, Teva, acquisition, cystic fibrosis, hepatitis C, pharma, top ten

It’s Friday the 13th, but that doesn’t change a strong showing from the industry this week as it continued to …
News
shutterstock_79370437

Hanmi terminates lung cancer drug after being muscled out by AZ’s Tagrisso

April 13, 2018 Medical Communications, Research and Development AstraZeneca, Cancer, Otila, Tagrisso, hanmi, lung cancer, pharma

South Korea’s Hanmi Pharmaceutical has announced its intention to terminate development of its lung cancer drug Olita (olmutinib) as it …
News
180405-evolution-of-kidney-cancer

Evolutionary path of kidney cancer tracked, “born to be bad” type discovered

April 13, 2018 Medical Communications, Research and Development Kidney cancer, biotech, drugs, pharma, pharmaceutical

A massive effort funded by Cancer Research UK has been able to track the different evolutionary pathways of kidney cancer …
News
eisa0003

Eisai forms partnership to find new tuberculosis treatment

April 13, 2018 Medical Communications, Research and Development Colorado State University, Eisai, broad institute, pharma, tuberculosis, university of chicago

Eisai has teamed up with the Broad Institute, the Mycobacteria Research Laboratories at Colorado State University and the University of …
News
roche__tree

Roche’s immunotherapy lucky streak ends with deaths in trial

April 13, 2018 Medical Communications, Research and Development Exelixis, Roche, biotech, drugs, pharma, pharmaceutical, tecentriq

Roche’s Tecentriq had begun to show signs of reviving its hopes in the competitive PD-1/L1 market, succeeding in two Phase …
News

Wickham Labs Announces Upcoming Webinar on Regulatory Changes in Medical Device Development

April 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wickham laboratories

Come join Wickham Laboratories and Patient Guard for this free webinar on May 23rd to discuss Regulatory Changes in Medical …
News
Press release
photo_ivana_magovcevic-liebisch3

Ipsen bolsters executive leadership with two new recruits

April 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma

Ipsen is set to expand its executive leadership team with the announcement of two new recruitments: Dr Ivana Magovčević-Liebisch will …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025